Westlake Omics （Hangzhou） Biotechnology Co., Ltd.
西湖欧米
Westlake Omics （Hangzhou） Biotechnology Co., Ltd.
Biotech/Healthcare
Westlake Omics has completed a Pre-A++ round exclusively backed by Ruijiang Kangsheng. The funding will support further R&D in AIVC virtual cells and clinical diagnostics and accelerate commercialization.
Latest round: Pre Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-07-17
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.